Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

September 01, 2025

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

May 16, 2025

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

December 03, 2024

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

October 29, 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

May 06, 2024

Hormonal Birth Control, NSAID Use Together Linked to VTE

News Daily News

Hormonal Birth Control, NSAID Use Together Linked to VTE

September 11, 2023

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

December 30, 2022

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

December 16, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

September 17, 2022

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

January 20, 2022

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

November 15, 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

November 03, 2021

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

News Daily News

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

June 23, 2021

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

News Daily News

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

June 22, 2021

FDA Approves Dabigatran for VTE in Children

News Daily News

FDA Approves Dabigatran for VTE in Children

June 22, 2021

EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE

News Daily News

EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE

January 15, 2021

Lasers Can Aid Retrieval of Stubborn IVC Filters

News Daily News

Lasers Can Aid Retrieval of Stubborn IVC Filters

December 02, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.